menu search

Enveric biosciences files provisional patent for cbd+celecoxib conjugate for osteoarthritis

Psychedelics-based neuroscience company Enveric Biosciences (NASDAQ: ENVB) announced the development of EV104a and EV104b, new molecular conjugates ...

February 8, 2022, 8:30 am

Enveric biosciences files provisional patent for cbd+celecoxib conjugate for osteoarthritis

Psychedelics-based neuroscience company Enveric Biosciences (NASDAQ: ENVB) announced the development of EV104a and EV104b, new molecular conjugates ...

February 8, 2022, 8:30 am

Enveric biosciences files provisional patent for cbd+celecoxib conjugate for osteoarthritis

Psychedelics-based neuroscience company Enveric Biosciences (NASDAQ: ENVB) announced the development of EV104a and EV104b, new molecular conjugates ...

February 8, 2022, 8:30 am

Abbvie's stock gains on fourth-quarter earnings as it reports better-than-expected sales of humana

Shares of AbbVie Inc. ABBV, +0.08% gained 1.4% in premarket trading on Wednesday after the company beat earnings expectations and generated more sales...

February 2, 2022, 8:06 am

Abbvie's stock gains on fourth-quarter earnings as it reports better-than-expected sales of humana

Shares of AbbVie Inc. ABBV, +0.08% gained 1.4% in premarket trading on Wednesday after the company beat earnings expectations and generated more sales...

February 2, 2022, 8:06 am

Abbvie's stock gains on fourth-quarter earnings as it reports better-than-expected sales of humana

Shares of AbbVie Inc. ABBV, +0.08% gained 1.4% in premarket trading on Wednesday after the company beat earnings expectations and generated more sales...

February 2, 2022, 8:06 am

Abbvie: skyrizi and rinvoq latest fda approvals bode well for humira patent loss

Recent FDA approval for Skyrizi was obtained for the treatment of adults with active psoriatic arthritis...

January 25, 2022, 1:32 pm

Abbvie: skyrizi and rinvoq latest fda approvals bode well for humira patent loss

Recent FDA approval for Skyrizi was obtained for the treatment of adults with active psoriatic arthritis...

January 25, 2022, 1:32 pm

Abbvie: skyrizi and rinvoq latest fda approvals bode well for humira patent loss

Recent FDA approval for Skyrizi was obtained for the treatment of adults with active psoriatic arthritis...

January 25, 2022, 1:32 pm

Abbvie's (abbv) skyrizi gets fda nod for psoriatic arthritis

AbbVie (ABBV) secures approval in the United States for Skyrizi to treat adult patients with active psoriatic ...

January 24, 2022, 10:49 am

Abbvie's (abbv) skyrizi gets fda nod for psoriatic arthritis

AbbVie (ABBV) secures approval in the United States for Skyrizi to treat adult patients with active psoriatic ...

January 24, 2022, 10:49 am

Abbvie's (abbv) skyrizi gets fda nod for psoriatic arthritis

AbbVie (ABBV) secures approval in the United States for Skyrizi to treat adult patients with active psoriatic ...

January 24, 2022, 10:49 am

Earnings outlook: what's next for a j&j that will soon be split into two different companies

Johnson & Johnson JNJ, +0.74% has long been viewed as a bellwether stock for other health care companies, given its early slot in the earnings calenda...

January 19, 2022, 12:02 pm

Earnings outlook: what's next for a j&j that will soon be split into two different companies

Johnson & Johnson JNJ, +0.74% has long been viewed as a bellwether stock for other health care companies, given its early slot in the earnings calenda...

January 19, 2022, 12:02 pm

Earnings outlook: what's next for a j&j that will soon be split into two different companies

Johnson & Johnson JNJ, +0.74% has long been viewed as a bellwether stock for other health care companies, given its early slot in the earnings calenda...

January 19, 2022, 12:02 pm

Novartis (nvs) gets fda nod for cosentyx's label expansion

The FDA approves Novartis' (NVS) Cosentyx for the treatment of children and adolescents with enthesitis-related ...

December 23, 2021, 1:03 pm

Novartis (nvs) gets fda nod for cosentyx's label expansion

The FDA approves Novartis' (NVS) Cosentyx for the treatment of children and adolescents with enthesitis-related ...

December 23, 2021, 1:03 pm

Novartis (nvs) gets fda nod for cosentyx's label expansion

The FDA approves Novartis' (NVS) Cosentyx for the treatment of children and adolescents with enthesitis-related ...

December 23, 2021, 1:03 pm

Clingen to distribute humanigen covid treatment in europe through managed access

Clinigen Group has set up an exclusive managed access program in Europe for Humanigen's anti-inflammatory drug lenzilumab. Humanigen is developing le...

October 8, 2021, 3:29 am

Clingen to distribute humanigen covid treatment in europe through managed access

Clinigen Group has set up an exclusive managed access program in Europe for Humanigen's anti-inflammatory drug lenzilumab. Humanigen is developing le...

October 8, 2021, 3:29 am


Search within

Pages Search Results: